S&P 500   4,662.85 (+0.08%)
DOW   35,911.81 (-0.56%)
S&P 500   4,662.85 (+0.08%)
DOW   35,911.81 (-0.56%)
S&P 500   4,662.85 (+0.08%)
DOW   35,911.81 (-0.56%)
S&P 500   4,662.85 (+0.08%)
DOW   35,911.81 (-0.56%)

McKesson Stock Forecast, Price & News

+1.77 (+0.69%)
(As of 01/14/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
705,303 shs
Average Volume
839,920 shs
Market Capitalization
$39.17 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive MCK News and Ratings via Email

Sign-up to receive the latest news and ratings for McKesson and its competitors with MarketBeat's FREE daily newsletter.

McKesson logo

About McKesson

McKesson Corp. engages in the provision of supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. It operates through the following segments: U.S. Pharmaceutical; International; Medical-Surgical Solutions; and Prescription Technology Solutions (“RxTS“). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; provides practice management, technology, clinical support, and business solutions to community-based oncology, and other specialty practices; and sells financial, operational, and clinical solutions to pharmacies and provides consulting, outsourcing, technological, and other services. The International segment provides distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The RxTS


McKesson (NYSE:MCK) Sets New 12-Month High at $256.00
January 13, 2022 |  americanbankingnews.com
Credit Suisse Group Upgrades McKesson (NYSE:MCK) to "Outperform"
January 7, 2022 |  americanbankingnews.com
McKesson (NYSE:MCK) Reaches New 1-Year High at $251.14
January 7, 2022 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Drugs, proprietaries, & sundries
Health Care Distributors
Year Founded

Sales & Book Value

Annual Sales
$238.23 billion
Cash Flow
$24.62 per share
Book Value
$1.10 per share


Net Income
$-4.54 billion
Pretax Margin




Free Float
Market Cap
$39.17 billion

Company Calendar

Last Earnings
Ex-Dividend for 1/3 Dividend
Dividend Payable
Next Earnings (Confirmed)
Fiscal Year End

Social Links


Overall MarketRank

2.62 out of 5 stars

Medical Sector

79th out of 1,417 stocks

Drugs, Proprietaries, & Sundries Industry

4th out of 7 stocks

Analyst Opinion: 2.5Community Rank: 5.0Dividend Strength: 2.5Insider Behavior: 2.5Valuation: 0.6 5 -4 -3 -2 -1 -

McKesson (NYSE:MCK) Frequently Asked Questions

Is McKesson a buy right now?

12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for McKesson in the last twelve months. There are currently 1 hold rating and 11 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" McKesson stock.
View analyst ratings for McKesson
or view top-rated stocks.

How has McKesson's stock been impacted by Coronavirus?

McKesson's stock was trading at $135.17 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, MCK stock has increased by 89.8% and is now trading at $256.52.
View which stocks have been most impacted by COVID-19

When is McKesson's next earnings date?

McKesson is scheduled to release its next quarterly earnings announcement on Wednesday, February 2nd 2022.
View our earnings forecast for McKesson

How can I listen to McKesson's earnings call?

McKesson will be holding an earnings conference call on Wednesday, February 2nd at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

How were McKesson's earnings last quarter?

McKesson Co. (NYSE:MCK) announced its quarterly earnings results on Sunday, October, 31st. The company reported $6.15 earnings per share for the quarter, topping the Zacks' consensus estimate of $4.66 by $1.49. The business earned $66.58 billion during the quarter, compared to the consensus estimate of $63.23 billion. McKesson had a negative net margin of 1.92% and a negative trailing twelve-month return on equity of 5,793.16%. The firm's revenue for the quarter was up 9.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $4.80 earnings per share.
View McKesson's earnings history

How often does McKesson pay dividends? What is the dividend yield for McKesson?

McKesson announced a quarterly dividend on Thursday, October 28th. Stockholders of record on Wednesday, December 1st will be paid a dividend of $0.47 per share on Monday, January 3rd. This represents a $1.88 annualized dividend and a yield of 0.73%. The ex-dividend date is Tuesday, November 30th.
View McKesson's dividend history

Is McKesson a good dividend stock?

McKesson pays an annual dividend of $1.88 per share and currently has a dividend yield of 0.73%.
View McKesson's dividend history.

How will McKesson's stock buyback program work?

McKesson announced that its board has initiated a stock buyback program on Tuesday, February 2nd 2021, which permits the company to buyback $2,000,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to reacquire up to 6.9% of its shares through open market purchases. Shares buyback programs are usually an indication that the company's board of directors believes its shares are undervalued.

What guidance has McKesson issued on next quarter's earnings?

McKesson updated its FY 2022 earnings guidance on Wednesday, December, 8th. The company provided EPS guidance of $22.350-$22.950 for the period, compared to the Thomson Reuters consensus estimate of $22.420. The company issued revenue guidance of -.

What price target have analysts set for MCK?

12 equities research analysts have issued twelve-month price targets for McKesson's shares. Their forecasts range from $230.00 to $333.00. On average, they expect McKesson's stock price to reach $277.42 in the next twelve months. This suggests a possible upside of 8.1% from the stock's current price.
View analysts' price targets for McKesson
or view top-rated stocks among Wall Street analysts.

Who are McKesson's key executives?

McKesson's management team includes the following people:

What is Brian Tyler's approval rating as McKesson's CEO?

220 employees have rated McKesson CEO Brian Tyler on Glassdoor.com. Brian Tyler has an approval rating of 88% among McKesson's employees.

Who are some of McKesson's key competitors?

What other stocks do shareholders of McKesson own?

Based on aggregate information from My MarketBeat watchlists, some companies that other McKesson investors own include Walt Disney (DIS), Johnson & Johnson (JNJ), Gilead Sciences (GILD), CVS Health (CVS), AbbVie (ABBV), Bank of America (BAC), AT&T (T), JPMorgan Chase & Co. (JPM), UnitedHealth Group (UNH) and Home Depot (HD).

What is McKesson's stock symbol?

McKesson trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK."

Who are McKesson's major shareholders?

McKesson's stock is owned by a variety of institutional and retail investors. Top institutional investors include Contravisory Investment Management Inc. (0.02%), DNB Asset Management AS (0.02%), Culbertson A N & Co Inc (0.02%), State of Alaska Department of Revenue (0.01%), Legacy Private Trust Co. (0.01%) and Park National Corp OH (0.01%). Company insiders that own McKesson stock include Brian S Tyler, Britt J Vitalone, Kevin Emerson, Lori A Schechter, Lori A Schechter, Marie L/Ca Knowles, Sundeep G Reddy, Thomas L Rodgers and Tracy Faber.
View institutional ownership trends for McKesson

Which institutional investors are selling McKesson stock?

MCK stock was sold by a variety of institutional investors in the last quarter, including Moody National Bank Trust Division, State of Alaska Department of Revenue, FCF Advisors LLC, IFP Advisors Inc, Culbertson A N & Co Inc, DNB Asset Management AS, Capital Investment Advisors LLC, and Beacon Financial Group. Company insiders that have sold McKesson company stock in the last year include Brian S Tyler, Britt J Vitalone, Kevin Emerson, Lori A Schechter, Sundeep G Reddy, Thomas L Rodgers, and Tracy Faber.
View insider buying and selling activity for McKesson
or view top insider-selling stocks.

Which institutional investors are buying McKesson stock?

MCK stock was bought by a variety of institutional investors in the last quarter, including Bremer Bank National Association, Diversified Trust Co, Park National Corp OH, Stratos Wealth Partners LTD., Abner Herrman & Brock LLC, Burt Wealth Advisors, Vigilant Capital Management LLC, and Legacy Private Trust Co..
View insider buying and selling activity for McKesson
or or view top insider-buying stocks.

How do I buy shares of McKesson?

Shares of MCK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is McKesson's stock price today?

One share of MCK stock can currently be purchased for approximately $256.52.

How much money does McKesson make?

McKesson has a market capitalization of $39.17 billion and generates $238.23 billion in revenue each year. The company earns $-4.54 billion in net income (profit) each year or ($30.10) on an earnings per share basis.

How many employees does McKesson have?

McKesson employs 80,000 workers across the globe.

Does McKesson have any subsidiaries?

The following companies are subsidiares of McKesson: A.L.I. Technologies, AMISYS Managed Care Systems, Abaton.com, Access Health, Biologics, Celesio, ClarusONE Sourcing Services LLP, CoverMyMeds, D & K Healthcare Resources, Drug Trading Co. Ltd., EN-Chart Scanning Program, Emendo, Enterprise Systems Inc., HBO & Company, HPR, HealthCom Partners, HealthQx, IMNET Systems, LloydsDirect, MED3000, McKesson Europe AG, McKesson Europe Holdings GmbH & Co. KGaA, McKesson Global Procurement & Sourcing Limited, McKesson International Bermuda IP2A Limited, McKesson International Bermuda IP3A Limited, McKesson International Bermuda IP5A Limited, McKesson Medical-Surgical Holdings Inc., McKesson Medical-Surgical Inc., McKesson Medical-Surgical Supply Chain Services LLC, McKesson Medical-Surgical Top Holdings Inc., McKesson Sourcing Services Inc., McKesson Specialty Care Distribution LLC, McKesson Strategic Services Limited, McKesson UK Finance I Limited, McKesson US Finance Corporation, McQueary Brothers, MedVentive, Medcon, MediVation Inc., Medical Specialties Distributors, Medis Health And Pharmaceutical Services, Monarch Insurance Company LLC, Moore Medical, NDCHealth, Northstar Healthcare Holdings Unlimited Company, Oncology Therapeutics Network, PSS World Medical, Per-Se Technologies, Portico Systems, Practice Partner, RedLine HealthCare, RelayHealth, Rexall, Rosebud Solutions, RxCrossroads, Sterling Medical Services LLC, UDG Healthcare, US Oncology, US Oncology Holdings Inc., US Oncology Inc., Vantage Oncology, Vivalog Technologies, Well.ca, and peerVue.

When was McKesson founded?

McKesson was founded in 1833.

What is McKesson's official website?

The official website for McKesson is www.mckesson.com.

Where are McKesson's headquarters?

McKesson is headquartered at 6555 STATE HWY 161, IRVING TX, 75039.

How can I contact McKesson?

McKesson's mailing address is 6555 STATE HWY 161, IRVING TX, 75039. The company can be reached via phone at (972) 446-4800, via email at [email protected], or via fax at 415-983-8453.

This page was last updated on 1/17/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.